MONEY

Akeso's Ivonescimab plus Chemo in First-Line Triple-negative Breast Cancer Showed Promising Preliminary Efficacy and Good Safety at ESMO 2024

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 16, 2024 - 16:00
Akeso's Ivonescimab plus Chemo in First-Line Triple-negative Breast Cancer Showed Promising Preliminary Efficacy and Good Safety at ESMO 2024
Read More

Tags:

Previous Article

More rivers spill banks in central European floods, death toll rises

Next Article

Jefferies sees Generali stock undervalued amid improved risk profile and profits

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Perimeter Medical Imaging AI Announces Closing of Non-Brokered Private Placement

Perimeter Medical Imaging AI Announces Closing of Non-B...

Tomas Kauer - Mode... Sep 30, 2024

Satoshi Nakamoto Iconic Bitcoin Line Marks 14 Years: Details

Satoshi Nakamoto Iconic Bitcoin Line Marks 14 Years: De...

Tomas Kauer - Mode... Jul 8, 2024

Venezuela's exiled opposition head says he was warned Maduro forces coming for him

Venezuela's exiled opposition head says he was warned M...

Tomas Kauer - Mode... Sep 21, 2024